Background: Few studies have described an association among acute liver disease, high short-term mortality, and blue-green refractile neutrophilic inclusions on blood smears.
with acute liver disease. [1] [2] [3] [4] The exact nature of these inclusions is unknown; however, it has been hypothesized that these inclusions represent lipofuscin or a lipofuscinlike substance based on staining characteristics, transmission electron microscopy (TEM) appearance, and autopsy findings of similar inclusions on Giemsa staining of liver biopsy material. 1 A relatively high rate of death within a short period of time has been reported in patients with these inclusions, but the significance of such findings is limited by the few cases reported. [1] [2] [3] [4] Herein, we describe a series of 13 case individuals from 1 institution that do not have as high an early mortality rate and whose illness is not universally associated with elevated liver enzymes.
Abbreviations TEM, transmission electron microscopy; PAS, periodic acid-Schiff; H&E, hematoxylin/eosin; LIS, laboratory information system; HLH, hemophagocytic lymphohistiocytosis; MGUS, monoclonal gammopathy of undetermined significance; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GMS, Gomori methenamine silver; SIRS, systemic inflammatory response syndrome; ARDS, acute respiratory distress syndrome; AKI, acute kidney injury; VRE, vancomycin resistant enterococcus; MGUS, monoclonal gammopathy of undetermined significance; CRI, chronic renal insufficiency; GVHD, graft versus host disease; HIV, human immunodeficiency virus; HHV6, human herpes virus 6; ILD, interstitial lung disease; ESRD, endstage renal disease; SLE, systemic lupus erythrematosis; SCC, squamouscell carcinoma; EBV, Ebstein-Barr virus; HLH, hemophagocytic lymphohistiocytosis/hemophagocytic syndrome; RAEB-1, myelodysplastic syndrome refractory anemia with excess blasts-1; HST: hematopoietic stem cell
Methods
This retrospective study was approved by the Institutional Review Board at the University of Minnesota, Minneapolis. We identified individuals with neutrophilic inclusions, as noted during routine clinical practice within a 5-year period.
In addition, we searched data in the laboratory information system (LIS) recorded between the years 2010 and 2015 for the terms debris and inclusion in peripheral blood specimens (isolated or part of a bone-marrow examination). Cases with neutrophilic inclusions that were determined to be organisms (based on characteristic morphologic characteristics) and cases with dark blue-gray to black nonrefractile inclusions were excluded from the study.
Of the 15,602 peripheral blood specimens and 10,413 bone marrow specimens from our institution between the years 2010 and 2015, a total of 13 cases with green-blue refractile inclusions were identified by these 2 methods. One of these cases was associated with a bone-marrow biopsy, and the remaining cases were identified via peripheral blood smears for pathologist review. We reviewed Wright Giemsa-stained slides in all 13 cases. Archived unstained slides were available for case 9; these were stained via hematoxylin/ eosin (H&E), periodic acid-Schiff (PAS), oil red O, myeloperoxidase, Giemsa, Gram stain, Ziehl-Neelson, and Prussian blue. We performed statistical analysis using a 2-tailed Fisher exact test using GraphPad Software QuickCalcs online (http://www.graphpad.com/quickcalcs/).
We performed a title search in PubMed for "neutrophilic inclusions", "neutrophil inclusions", and "green inclusions". Also, we identified 1 reference (abstract) during attendance at a national meeting.
Results

Literature Review
A total of 25 cases of green-blue neutrophilic inclusions have been reported in the literature, most of which were in a case series of 20 patients, in addition to 3 case reports of 1 to 2 cases each. [1] [2] [3] [4] Seventeen of the 25 patients (68%) died within 2 weeks of detection of the neutrophilic inclusions. The length of follow-up for the surviving patients was not given.
Acute liver failure and/or elevation of liver enzymes were present in all but 1 of the 25 cases described in the literature. The 1 patient who lacked significant elevation of liver enzyme levels was diagnosed with acute myocardial infarction and died on day 1 of her stay in the hospital. 1 
Additional Cases from Our Institution
Thirteen case individuals were identified as having greenblue refractile inclusions ( Figure 1 , parts A-C), matching the morphologic appearance described by previous studies. The inclusions were observed in neutrophils only (11 cases), neutrophils and monocytes (case 9), or monocytes only (case 4). In all but 2 cases (namely, cases 12 and 13), the inclusions were present in a small percentage of neutrophils or monocytes (2% or less). In both cases with a higher percentage, neutropenia was present, with relatively few neutrophils counted. In the single case with additional stains (namely, case 9), the inclusions were acid fast on ZiehlNeelson staining ( Figure 1D ). No staining by PAS, oil red O, myeloperoxidase, Giemsa, or Prussian blue yielded positive results; however, inclusions were not definitively identified on all stains due to the low percentage of cells with inclusions.
In addition, oil red O had high background precipitate staining. These cases have been identified slightly more often in the past 1.5 years as pathologist awareness of these inclusions has increased-5 cases have been identified during this most recent period. In contrast, the previous rate was 1 to 2 cases per year, all identified by a single technologist (S.C.).
Clinical details of the patients are outlined in Table 1 . Our cohort of 13 patients showed a wide age range, from age 12 years to 81 years (median, 60 years), and a relatively equal sex distribution, with a male to female ratio of 5:8. At the time of peripheral smear review, most of the patients were hospitalized due to an acute illness and had significant comorbidities. Seven patients had a history of cancer, and 4 patients had received a transplant (2 lung and 2 hematopoietic stem cells). Eleven of the patients (85%) had a proven or suspected infection, 4 patients had autoimmune disease, and 2 patients had hemophagocytic lymphohistiocytosis (HLH). Seven of the 13 patients were taking antibiotics. The most common antibiotic was oral vancomycin (4 patients), followed by prophylactic doses of sulfamethoxazole/trimethoprim (3 patients), and meropenem and micafungin (2 patients each). Six patients were either not taking antibiotics (3 patients) or were given antibiotics at approximately the same time as the blood specimen was taken for the blood smear (3 patients). Five patients were taking immunosuppressive medications, most commonly corticosteroids (5 patients), followed by tacrolimus (3 patients). As expected, these medications were used in patients with an underlying diagnosis of transplant or autoimmune disease.
In contrast to most of the patients comprising our proband group and those whose cases were reported in the literature, 2 patients were not critically ill and did not have evidence of infection. One man (case 4) was 81 years old and being treated on an outpatient basis, with inclusions only in monocytes. He had a history of prostate cancer (treated 3 years previously with surgical procedure[s] and radiotherapy), chronic renal insufficiency, anemia, and a monoclonal gammopathy of undetermined significance (MGUS) but no obvious acute illness ( Figure 1C) . A follow-up blood smear 3 months later yielded negative results for inclusions. This patient was followed up for more than 2 years after the inclusions were identified and experienced no adverse outcome. Another patient with neutrophilic inclusions had bipolar disorder (case 11) and was hospitalized for 3 days for malnourishment-related coagulopathy, which was treated with vitamin K therapy. This patient was lost to follow-up after discharge.
Figure 1
Neutrophilic inclusions, which are blue-green globular in shape and refractile, as found in specimens from 13 case individuals. A, Case 1, Wright-Giemsa Â100. B, Case 9, Wright-Giemsa Â100. C, Blue-green inclusions observed in monocytes in 2 cases (case 4, Wright-Giemsa Â100). D, Acid fast inclusions, as determined by Ziehl Neelson staining (case 9, Ziehl Neelson Â100). Six of the patients in our cohorts had died at last follow up (median, 32 days; range, 3-2009 days); however, 2 of the deaths occurred long after identification of the inclusions (197 and 599 days afterward, respectively). These patients had recovered from their acute illness and had later died of other causes. The other 4 deaths occurred 6, 7, 18, and 32 days from identification of the inclusions, respectively, which yielded a 31% short-term mortality rate, defined as the rate of death occurring within the initial period of hospitalization (P ¼ .04, compared with the 68% mortality rate reported in the literature). Further, all deaths reported in the literature occurred within 2 weeks; by contrast, only 2 patients in our cohort had died during that period (15% mortality rate; P ¼ .005, compared with the mortality rate reported in the literature). The patient who died at 32 days after hospitalization (case 7) seemed to initially recover in the hospital but subsequently became seriously ill. All four patients with autoimmune disease died, although one of these (case 6) was a late death that occurred 197 days after presentation. Two of the 4 patients who had undergone transplantation died; 1 of the 2 was a late death (this patient also had autoimmune disease).
Of the 12 patients who underwent liver enzyme levels testing, 8 had significant elevations of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ( Table 2 ). All 4 patients who died early (during their initial hospitalization) had elevated liver enzyme levels. Alkaline phosphatase (ALP) levels were elevated in 7 of 12 patients; there was no statistical difference in outcome based on elevation of ALP level. All 10 patients tested had elevated lactate dehydrogenase (LDH) levels, including 3 patients with normal liver enzyme levels. Cytopenias of 1 or more lineages were common and they varied from slight to marked cytopenia. The presence or degree of cytopenia(s) showed no correlation with short-term mortality rate. Lactic acid levels were elevated in 75% of the patients who died early in the initial hospitalization period, but these levels were also elevated in 60% of the remaining patients who were tested. Hyperbilirubinemia showed no association with early death.
Discussion
Refractile green-blue neutrophil inclusions have been described in critically ill patients with evidence of acute liver injury; these inclusions have been associated with high short-term mortality. It has been proposed that these inclusions occur due to significant liver injury; however, our detection of inclusions in 4 patients with no significant elevation of liver enzyme levels cannot be explained by this mechanism. There is the possibility that the inclusions are related to tissue injury, with hepatic injury representing 1 type of tissue injury. We measured LDH levels in 3 of the patients with normal liver enzyme levels, and this value turned out to be elevated in all 3. One patient had a diagnosis of tissue injury (tumor lysis syndrome), and tissue injury was a possible cause of an elevated LDH in the other 2 patients because neither harbored a hematopoietic neoplasm. However, we also detected inclusions in a relatively healthy man, who was being treated on an outpatient basis and had no evidence of acute disease. The presence of inclusions in this patient is not explained by the aforementioned theory. Although this patient may have had subclinical tissue injury, the inclusions occurred only in monocytes; this finding raises the possibility of a different pathophysiologic process.
In a study by Hodgson et al, 1 the inclusions yielded positive results via oil red O, showed acid fast characteristics via long Ziehl-Neelsen staining, and showed osmiophilic (lipid-rich) cytoplasmic inclusions by transmission electron microscopy (TEM), whereas results were negative on iron, myeloperoxidase, Warthin-Starry, Gomori methenamine silver (GMS), PAS, and Gram staining. The authors hypothesized that the inclusions were lipofuscin or lipofuscin-like, although they acknowledged that the lack of PAS staining and lack of autofluorescence are atypical for lipofuscin. 1 The inclusions that we detected in 1 of our case Lastly, inclusions may be detected but ignored or not reported because of lack of awareness of their significance, which has only recently been reported in the literature. [1] [2] [3] [4] For example, in 2 of our cases, despite inclusions being identified, the presence of the inclusions was not noted in the final report.
Although the probands in our study still had a relatively high short-term mortality rate (31%), it was less than that reported in the literature (68%). The reason for this difference is unclear, although it could be related to the small number of cases. As suggested previously in the literature, we believe that the presence of these inclusions and their association with elevated liver enzyme levels should be reported. It may be especially useful to alert the healthcare professionals caring for the patient to consider evaluating for liver (or possibly tissue) damage and lactic acidosis. However, we suggest that it may be less useful to report the mortality rate: doing so could cause undue alarm for a patient who is not critically ill (such as our case 4). One option is to report that these neutrophilic inclusions have been associated with short-term mortality in critically ill hospitalized patients.
In this retrospective study from 1 institution, we report on 13 additional cases of neutrophils and/or monocytes with green-blue refractile material, as well as providing a summary of the literature on this topic. Our findings were similar to those reported previously, with the exceptions of a lower, although still generally high, short-term mortality rate, and the fact that our findings did not reveal universally elevated liver-enzyme levels. We believe that the presence of these inclusions should be reported, along with the association with elevated liver-enzyme levels and an elevated LDH level. These comments may prompt examination of these parameters if not previously analyzed, which could impact patient care. We propose that greater awareness of these inclusions and their potential implications will lead to more-frequent identification and further investigation into their etiology and significance. LM
